You are here: Industry Insights > COVID-19 Vaccine

News List

Johnson & Johnson prepares to resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 vaccine candidate in the U.S. worldpharmanews
October 28, 2020
Johnson & Johnson is preparing to resume recruitment in the pivotal Phase 3 ENSEMBLE trial of its investigational Janssen COVID-19 vaccine in the United States after a temporary pause.
Oxford COVID-19 vaccine trials produce robust immune response in elderly: FT expresspharma
October 27, 2020
The COVID-19 vaccine being developed by the University of Oxford and AstraZeneca produces a robust immune response in elderly people, the Financial Times said on Monday, citing early results.
Indian company Dr Reddy’s isolates data centres after cyber attack pharmaceutical-technology
October 26, 2020
Indian Covid-19 vaccine manufacturer Dr Reddy’s Laboratories has isolated all its data centres after it suffered a cyber attack.
Second wave of COVID-19 vaccines may not be needed to reach higher efficacy bar than first batch expresspharma
October 26, 2020
It would be best for second wave vaccines to underscore ideal subpopulations or manufacturing and storage advantages that could underscore uptake.
Bharat Biotech in talks with many countries for clinical trials, manufacture of COVAXIN expresspharma
October 26, 2020
Bharat Biotech is in discussions with more than 10 countries that have shown an interest in its potential COVID-19 vaccine, a company executive told Reuters.
Canada to invest up to C$214 mn for R&D of home grown COVID-19 vaccines: Trudeau expresspharma
October 26, 2020
Canada will invest up to C$214 million ($162.8 million) to help develop a domestically made COVID-19 vaccine, and it has secured up to 76 million doses of Quebec City-based Medicago’s potential vaccine, Prime Minister Justin Trudeau said on Friday.
Vaccine verdict due by early December: Anthony Fauci expresspharma
October 26, 2020
US infectious disease expert Anthony Fauci said it would be clear whether a COVID-19 vaccine was safe and effective by early December, but that more widespread vaccination would not be likely until later in 2021.
Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine prnewswire
October 23, 2020
Amyris, Inc., a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced the signing of a Collaboration Agreement and License Agreement ...
Work to develop a COVID-19 vaccine is faster than ever worldpharmanews
October 23, 2020
While the Americas urgently awaits a breakthrough, the Pan American Health Organization (PAHO) will only support the distribution of a vaccine that has proven to be safe and effective in clinical trials, reviewed by National Regulatory Authorities and ...
A vaccine project funded by the Federal Ministry for Economic Affairs and Energy develops a second generation COVID-19 vaccine worldpharmanews
October 23, 2020
A vaccine project funded by the EXIST programme initiated by the Federal Ministry for Economic Affairs and Energy (Germany) is developing a second generation Covid-19 vaccine.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page